IPRIPR2021-01336Terminated-Settled
Fresenius Kabi USA, LLCv.Chugai Seiyaku Kabushiki Kaisha (Chugai Pharmaceutical Co., Ltd.)
IPR challenge of US 10874677.
Type
IPR
Filed
Aug 18, 2021
Instituted
Feb 23, 2022
Decided
Oct 17, 2022
Patent
Application
16254105
Inventor
XIAOPING ZHANG et al
Granted
Dec 29, 2020
01
Timeline
3 milestones
2021-08-18Petition filed
2022-02-23Institution
2022-10-17Terminated
02
Parties & counsel
Petitioner
Fresenius Kabi USA, LLC
Counsel
Elizabeth Holland
Patent Owner
Chugai Seiyaku Kabushiki Kaisha (Chugai Pharmaceutical Co., Ltd.)
Counsel
Thomas Fletcher
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →